The flaxseed lignan secoisolariciresinol diglucoside was demonstrated to reduce tumor growth in the E0771 TNBC mice model, likely by inhibiting NF-κB activity (Bowers et al., 2019). The gene discussed is NFKB1; the disease is neoplasm.